A backbone called BIRAC
From the day it came into existence, the Biotechnology Industry Research Assistance Council (BIRAC), an institution set up by the…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Cover Story » Page 2
Browsing Category
Cover Story
‘Startups must make sure their idea has a market need’
Entrepreneurs’ journey is complex, and with biotechnology, it becomes more complex. However, more than 20 per cent of our…
‘We expect further fine tuning of the existing schemes and policies’
Suresh Pareek, Managing Director, Ideal Cures
The implementation of various schemes and policies by the NDA government has…
‘Hoping that the future of Indian Pharma is brighter than before’
Dr Ajit Dangi, President & CEO, Danssen Consulting
While most reforms carried out by the Modi Government in the past four…
‘I expect more bold initiatives on macro-economic front’
Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates
The Modi Government has been following a policy of concentrating on macro…
‘Funding for pharma companies might be a way to move forward’
Dr Dinesh Dua, Chairman,Pharmexcil, Chairman, Entrepreneurship & Start Ups, CII North India,CEO & Director, Nectar…
‘There is a definite need to support SME upgradation’
Harish Jain, Secretary and Sunil Attavar, President, Karnataka Drugs & Pharmaceuticals Manufacturer’s Association
There is no…
‘We expect the new govt to reduce regulatory intervention’
BR Sikri, Chairman, Fope
First let me highlight the good things done by the present government.:
Recently agreed to publish SQ…
A report card and a wishlist
Demonetisation, Swachh Bharat Abhiyan, Make in India, Digital India, Ayushmaan Bharat and implementation of GST have been the…
Price cap on onco drugs: Will it have the desired impact?
NPPA’s recent move to cap the price of 42 non-scheduled cancer drugs has evoked mixed reactions from the industry. While some…